JP2023546764A5 - - Google Patents

Info

Publication number
JP2023546764A5
JP2023546764A5 JP2023502585A JP2023502585A JP2023546764A5 JP 2023546764 A5 JP2023546764 A5 JP 2023546764A5 JP 2023502585 A JP2023502585 A JP 2023502585A JP 2023502585 A JP2023502585 A JP 2023502585A JP 2023546764 A5 JP2023546764 A5 JP 2023546764A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
acid sequence
cdr1
cdr2
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023502585A
Other languages
English (en)
Japanese (ja)
Other versions
JP7829546B2 (ja
JP2023546764A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2021/106892 external-priority patent/WO2022012683A1/en
Publication of JP2023546764A publication Critical patent/JP2023546764A/ja
Publication of JP2023546764A5 publication Critical patent/JP2023546764A5/ja
Application granted granted Critical
Publication of JP7829546B2 publication Critical patent/JP7829546B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023502585A 2020-07-16 2021-07-16 Ｃｄ１９結合分子及びその使用 Active JP7829546B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN2020102457 2020-07-16
CNPCT/CN2020/102457 2020-07-16
PCT/CN2021/106892 WO2022012683A1 (en) 2020-07-16 2021-07-16 Cd19 binding molecules and uses thereof

Publications (3)

Publication Number Publication Date
JP2023546764A JP2023546764A (ja) 2023-11-08
JP2023546764A5 true JP2023546764A5 (https=) 2024-07-11
JP7829546B2 JP7829546B2 (ja) 2026-03-13

Family

ID=79554496

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023502585A Active JP7829546B2 (ja) 2020-07-16 2021-07-16 Ｃｄ１９結合分子及びその使用

Country Status (9)

Country Link
US (1) US20230192883A1 (https=)
EP (1) EP4182351A4 (https=)
JP (1) JP7829546B2 (https=)
KR (1) KR20230038706A (https=)
CN (1) CN116457464A (https=)
AU (1) AU2021309145A1 (https=)
CA (1) CA3186065A1 (https=)
IL (1) IL299867A (https=)
WO (1) WO2022012683A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3120563A1 (en) 2018-11-26 2020-06-04 Nkarta, Inc. Methods for the simultaneous expansion of multiple immune cell types, related compositions and uses of same in cancer immunotherapy
EP3773918A4 (en) 2019-03-05 2022-01-05 Nkarta, Inc. CD19 DIRECTED CHIMERIC ANTIGEN RECEPTORS AND THEIR USES IN IMMUNOTHERAPY
JP7846667B2 (ja) 2020-07-16 2026-04-15 レジェンド バイオテック アイルランド リミテッド Ｃｄ２０結合分子及びその使用
WO2025029930A1 (en) 2023-07-31 2025-02-06 Legend Biotech Ireland Limited Cells overexpressing cd31 and methods of use thereof
WO2025137089A1 (en) * 2023-12-19 2025-06-26 Beam Therapeutics Inc. Cd19-binding polypeptides, compositions comprising the same, and methods for use thereof
WO2025214438A1 (zh) * 2024-04-10 2025-10-16 浙江纳米抗体技术中心有限公司 结合cd19和/或cd22的抗原结合分子及其用途
WO2026035951A2 (en) 2024-08-07 2026-02-12 Legend Biotech Ireland Limited Cells overexpressing cd43 and methods of use thereof
WO2026055226A1 (en) 2024-09-03 2026-03-12 Legend Biotech Ireland Limited Cells overexpressing b3gnt2 and methods of use thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0624500D0 (en) * 2006-12-07 2007-01-17 Istituto Superiore Di Sanito A novel passive vaccine for candida infections
WO2010130832A2 (en) * 2009-05-15 2010-11-18 Ablynx N.V. Amino acid sequences directed against dickkopf-1 and polypeptides comprising the same for the treatment of diseases and disorders associated with bone loss and/or osteolytic lesions
CA2874083C (en) * 2014-12-05 2024-01-02 Universite Laval Tdp-43-binding polypeptides useful for the treatment of neurodegenerative diseases
CN105384825B (zh) * 2015-08-11 2018-06-01 南京传奇生物科技有限公司 一种基于单域抗体的双特异性嵌合抗原受体及其应用
EP3293199B1 (en) * 2016-09-08 2021-01-13 Heinrich-Heine-Universität Düsseldorf Chimeric antigen receptors
CN108276493B (zh) * 2016-12-30 2023-11-14 南京传奇生物科技有限公司 一种嵌合抗原受体及其应用
CN106939048A (zh) * 2017-03-25 2017-07-11 康众（北京）生物科技有限公司 一种CD3ε×CD19双特异性纳米抗体及其制备方法
BR112020024074A2 (pt) * 2018-07-20 2021-02-17 Teneobio, Inc. anticorpos de cadeia pesada com ligação a cd19
KR20210111244A (ko) * 2018-11-30 2021-09-10 셀룰래리티 인코포레이티드 태반-유래 동종이계 car-t 세포 및 이의 용도
CN110396128B (zh) * 2019-03-21 2022-09-06 南京东极医药科技有限公司 抗cd19纳米抗体的制备

Similar Documents

Publication Publication Date Title
JP2023546764A5 (https=)
FI3334765T3 (fi) Yksidomeenivasta-aineisiin perustuvia kimeerisiä antigeenireseptoreita ja menetelmiä niiden käyttämiseksi
JP2025028239A5 (https=)
JP2023546766A5 (https=)
JP7444790B2 (ja) 癌を治療する方法及びｔ細胞リダイレクト治療薬の有効性を向上させる方法
TWI879275B (zh) 新型抗CD3ε抗體
JP2021087455A5 (https=)
US12098210B2 (en) Methods of treating cancers and enhancing efficacy of BCMAxCD3 bispecific antibodies
JP2022542543A5 (https=)
US20240052052A1 (en) Novel anti-cd24 antibodies
JP7854121B2 (ja) 微小ガイダンス及びナビゲーションコントロール（ｍｉｎｉＧＮＣ）抗体様タンパク質、その製造方法及び使用方法
CA3020864A1 (en) Novel b7-h3-binding molecules, antibody drug conjugates thereof and methods of use thereof
RU2020120853A (ru) Мультиспецифичные химерные рецепторы, содержащие домен nkg2d, и способы их применения
TW201942134A (zh) 結合cd33、nkg2d及cd16之多特異性結合蛋白及使用方法
JP2018503380A5 (https=)
JP2023524997A5 (https=)
JP2022513682A5 (https=)
TW202448957A (zh) 抗cd3抗體及含有該抗體的分子、及其製造方法
JP2023546765A5 (https=)
JP2023554467A5 (https=)
JP2024502094A5 (https=)
WO2025045018A1 (en) Anti-gamma delta tcr antibodies and uses thereof
WO2025157223A1 (en) Multispecific antibodies and uses thereof
KR20260062933A (ko) 항-γδ TCR 항체 및 이의 용도
EA052500B1 (ru) Новые антитела против cd24